Sales Momentum Builds as geko® Device Adoption Accelerates Across UAE Hospitals

04 Jun Sales Momentum Builds as geko® Device Adoption Accelerates Across UAE Hospitals

Sky celebrates its rapidly expanding footprint in the UAE, with geko® device adoption in a further three leading Dubai hospitals: Genesis Healthcare, Dubai London Hospital, and Mediclinic Parkview Hospital. These latest partnerships, signal accelerating regional demand and mark a key milestone in Sky’s broader Middle East expansion strategy and sales momentum. Click here to read press article.

Clinicians at the hospitals are deploying the geko device to accelerate chronic wound healing, reduce lower limb oedema (swelling), following orthopaedic surgery and orthopaedic trauma, and to prevent deadly blood clots in medically ill and immobile patients.

Traditional therapies such as compression bandaging and anticoagulants, although effective, can often fall short due to patient discomfort, application complexity, or bleeding risks. The geko device overcomes these complexities, delivering a safe, non-invasive, and easy-to-use alternative when standard of care cannot be prescribed – and in respect to oedema control – breaks new ground in addressing a burden that, until now, has had few tools to resolve pre- and post-operative swelling complications – complications that can impede wound closure, decrease muscle strength and stall rehabilitation^1,2.

Dr Ibrahim Riza, Consultant Vascular and Endovascular Surgeon, describes the geko device as “game-changing,” noting its effectiveness not only in standard indications like VTE prevention but also in addressing lymphedema, and oedema related to maternity and travel.

“By offering my patients the geko device, I provide them with a safe, comfortable, and effective way to support their vascular health, without the need for drugs or bulky equipment.”

Sky’s expansion across the UAE is central to its mission to improve patient outcomes and reduce healthcare system costs with advanced, drug-free solutions.

With the global wound care market projected to reach $27.6 billion by 2027, the VTE treatment space growing toward $4.8 billion by 2030, and the global lower limb orthopaedic and trauma-based oedema market expected to surpass $21 billion by 2028^3,4, demand for non-invasive, scalable solutions like the geko® device continues to rise. Sky’s growing presence in the UAE reinforces its position as a leader in next-generation medtech – and sets the stage for rapidly mounting regional and international growth.

References:

1. 1. Holm B, et al. Loss of Knee-Extension Strength Is Related to Knee Swelling After Total Knee Arthroplasty. Archives of Physical Medicine and Rehabilitation. Volume 91, Issue 11, P1770-1776, NOVEMBER 01, 2010. DOI: https://doi.org/10.1016/j.apmr.2010.07.229.
   2. Kluga K, et al. Improving Orthopedic-Related Postoperative Edema Management in a Rehabilitative Nursing Setting. Rehabil Nurs. May/Jun 2019;44(3):151-160. doi: 10.1097/rnj.0000000000000104.
   3. Wound Care Market to Garner $27.2 billion by 2027 –
   4. Global Venous Thromboembolism Treatment Market Size to